SGI
BDSI

Summit Global Investments’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Summit Global Investments’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-129,700
Closed -$468K – 659
2021
Q3 		$468K Buy
129,700
+16,400
+14% +$61.9K 0.04% 322
2021
Q2 		$406K Buy
+113,300
New +$400K 0.02% 393

Other funds holding BDSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Summit Global Investments's BDSI Position: Q4 2021 in Review

Summit Global Investments sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2021, closing a stake of 129,700 shares — an estimated $468K sold.

Summit Global Investments first reported a position in BDSI in Q2 2021 and held it in 2 quarters. The position peaked at $468K in Q3 2021. 156 funds tracked by Wall St. Rank hold BDSI as of Q4 2021.

  • Summit Global Investments reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2021 after selling out during the quarter.
  • Summit Global Investments sold 129,700 BioDelivery Sciences International, Inc. shares in Q4 2021, an estimated $468K.
  • Summit Global Investments first reported a position in BioDelivery Sciences International, Inc. in Q2 2021 and held it in 2 quarters.
  • Summit Global Investments's BioDelivery Sciences International, Inc. position peaked at $468K in Q3 2021.
  • 156 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2021.

Based on Summit Global Investments's 13F filing for Q4 2021, filed 14 Feb 2022.